Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on: May 29,2024

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on:May 29,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on: June 28,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on:June 28,2024

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on: June 03,2024

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on:June 03,2024

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on: July 19,2024

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on:July 19,2024

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Updated on: April 03,2024

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Updated on:April 03,2024

Alcoholic liver disease in China: A disease influenced by complex social factors that should not be neglected

by Xia & He PublishingAlcoholic liver disease (ALD) encompasses liver damage caused by chronic, excessive alcohol consumption. Credit: Tao Sun, Bing Zhang, Xiaofeng Feng, Nafei HuangAlcoholic live

Updated on: July 19,2024

Alcoholic liver disease in China: A disease influenced by complex social factors that should not be neglected

by Xia & He PublishingAlcoholic liver disease (ALD) encompasses liver damage caused by chronic, excessive alcohol consumption. Credit: Tao Sun, Bing Zhang, Xiaofeng Feng, Nafei HuangAlcoholic live

Updated on:July 19,2024

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on: July 01,2024

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on:July 01,2024

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on: March 20,2024

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on:March 20,2024

Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

by Karolinska InstitutetGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.08.018Close relatives of people with metabolic-associated fatty liver disease

Updated on: May 26,2024

Liver cancer and severe liver disease found to be more common if a close relative has fatty liver disease

by Karolinska InstitutetGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.08.018Close relatives of people with metabolic-associated fatty liver disease

Updated on:May 26,2024

Alcoholic pancreatitis patients with continued alcohol intake may finally have therapeutic options

by University of MiamiGraphical abstract. Credit:American Journal of Physiology-Gastrointestinal and Liver Physiology(2022). DOI: 10.1152/ajpgi.00159.2022Many alcoholic pancreatitis p

Updated on: July 04,2024

Alcoholic pancreatitis patients with continued alcohol intake may finally have therapeutic options

by University of MiamiGraphical abstract. Credit:American Journal of Physiology-Gastrointestinal and Liver Physiology(2022). DOI: 10.1152/ajpgi.00159.2022Many alcoholic pancreatitis p

Updated on:July 04,2024

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on: June 12,2024

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on:June 12,2024

Inosine is a promising metabolite for enhancing mitochondrial function and cellular potency

Updated on: May 29,2024

Inosine is a promising metabolite for enhancing mitochondrial function and cellular potency

Updated on:May 29,2024